Drug Research

Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to treat lower respiratory tract sickness caused by the respiratory syncytial virus (RSV) in neonates and young children. If authorised, Beyfortus,...

Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will give academia and business exposure to cross-cutting services and assistance from fundamental science up to clinical application over the...

The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on the grounds that Omicron and the variant's most recent offspring have probably made them ineffective. The two treatments were among the first drugs created in...

Despite the increased prevalence of both communicable and non-communicable diseases in the nation, the commercial potential for medication manufacturers in Cambodia will remain restricted, according to a report by Fitch Solutions. Based on the report, Cambodia's healthcare system is still...

Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a steep price tag of $2.5 million for each treatment. In a preliminary evidence report made...

The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously. At least 17 million people in the 53 Member States of the WHO European Region may have encountered post-COVID-19...

The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its capabilities and capacity for early technological development of biologics, the multi-year investment will be deployed...